| abstract |
Disclosed is a novel antitumor agent containing, as an active ingredient, a compound inhibiting binding between an acetylated histone and a bromodomain-containing protein, preferably a thienotriazolodiazepine compound represented by the general formula (I) below or a pharmaceutically acceptable salt thereof, or a hydrate or solvate of any of those. (In the formula, the symbols are as defined in the description.) |